• Source: Respimat

Respimat, also known as Respimat Soft Mist Inhaler, is a drug delivery device used for the treatment of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions.
Its developer, Boehringer Ingelheim, is currently conducting approved in the U.S. with a variety of their products, such as tiotropium and ipratropium/salbutamol. According to the manufacturer, the reusability of the inhaler reduces its carbon footprint by 71%.




References






Sources


Home — Respimat International

Kata Kunci Pencarian:

• Tiotropium bromida
• Respimat
• Tiotropium bromide
• Olodaterol
• Ipratropium bromide/salbutamol
• Pulmonary drug delivery
• Beta2-adrenergic agonist
• Nebulizer
• Long-acting beta-adrenoceptor agonist
• Commonly prescribed drugs